Numerous basic and clinical studies have suggested that the systemic inflammatory response may induce the production and secretion of inflammatory cytokines, prostaglandins, and vascular endothelial growth factor, inflammatory mediators that accelerate the proliferation of cancer cells, leading to disease progression in previously undetectable metastatic lesions (3, 4). Here, VEGFA is linked to cancer.